These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38925826)
1. Comparative Analysis of Clinical Characteristics and Prognosis Between Primary Lung Cancers Identified as Screening Detected and Incidentally Detected Pulmonary Nodules. Zo S; Kim C; Lee HY; Park G; Shin SH; Jeong BH; Lee K; Kim H; Kim HK; Um SW Anticancer Res; 2024 Jul; 44(7):3163-3173. PubMed ID: 38925826 [TBL] [Abstract][Full Text] [Related]
2. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638 [TBL] [Abstract][Full Text] [Related]
3. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study. Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848 [TBL] [Abstract][Full Text] [Related]
4. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry. Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105 [TBL] [Abstract][Full Text] [Related]
5. Preliminary Investigation and Imaging Analysis of Early Lung Cancer Screening Among Petroleum Workers in North China. Guo ZJ; Zhang Q; Liu Y; Bai ZM; Qiang L; Li HY; Zhang YH; Chi HW; Men M; Xu Q; Liang F; Feng WQ; Lu JY; Liu HT; Zeng YH Cancer Invest; 2021 Apr; 39(4):321-332. PubMed ID: 33645376 [TBL] [Abstract][Full Text] [Related]
6. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram. Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097 [TBL] [Abstract][Full Text] [Related]
7. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862 [TBL] [Abstract][Full Text] [Related]
8. [Pulmonary nodules - an overview]. Martini K; Eberhard M; Frauenfelder T Ther Umsch; 2020; 77(2):75-80. PubMed ID: 32633224 [TBL] [Abstract][Full Text] [Related]
10. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models. Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866 [TBL] [Abstract][Full Text] [Related]
11. Brief Report: Nonmalignant Surgical Resection Among Individuals with Screening-Detected Versus Incidental Lung Nodules. Till BM; Grenda T; Tidwell T; Wickes B; Shusted C; Ruane B; Okusanya O; Evans NR; Barta JA Clin Lung Cancer; 2024 May; 25(3):e129-e132.e4. PubMed ID: 38185612 [No Abstract] [Full Text] [Related]
12. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study. Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006 [TBL] [Abstract][Full Text] [Related]
13. Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses. Rampinelli C; Minotti M; Ancona E; Preda L; Bertolotti R; Summers P; Raimondi S; Bagnardi V; Bellomi M Eur Radiol; 2019 Jul; 29(7):3862-3870. PubMed ID: 31062136 [TBL] [Abstract][Full Text] [Related]
14. Probability of cancer in pulmonary nodules detected on first screening CT. McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118 [TBL] [Abstract][Full Text] [Related]
16. Risk of Malignancy in Incidentally Detected Lung Nodules in Patients Aged Younger Than 35 Years. Byrne SC; Peers C; Gargan ML; Lacson R; Khorasani R; Hammer MM J Comput Assist Tomogr; 2024 Sep-Oct 01; 48(5):770-773. PubMed ID: 38438334 [TBL] [Abstract][Full Text] [Related]
17. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening. Hadique S; Jain P; Hadi Y; Baig A; Parker JE BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221 [TBL] [Abstract][Full Text] [Related]
18. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines. van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773 [TBL] [Abstract][Full Text] [Related]
19. Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program. LeMense GP; Waller EA; Campbell C; Bowen T BMC Pulm Med; 2020 Apr; 20(1):115. PubMed ID: 32349709 [TBL] [Abstract][Full Text] [Related]
20. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer. Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]